Huang, Jin (2021) The Prospect of Treating Alzheimer Disease through Sleep. Journal of Pharmaceutical Research International, 32 (40). pp. 49-53. ISSN 2456-9119
Huang32402020JPRI63360.pdf - Published Version
Download (213kB)
Abstract
Alzheimer's disease is caused by the deposition of amyloid and Tau proteins. These two proteins are present in normal brain cells, but in Alzheimer's disease, they accumulate in large quantities, affecting how brain cells function normally. The result is that brain cells can't communicate properly, leading to memory loss. The current treatment for Alzheimer's disease is mostly controlled by drugs. The three main drugs are Donepezil, Rivastigmine, and Galantamine, Reminyl. However, it has limited side effects and usually manifests as gastrointestinal distress. One of the functions of sleep is to accelerate the removal of amyloid in the brain, which can effectively improve the accumulation of amyloid and Tau proteins.
Item Type: | Article |
---|---|
Subjects: | Souths Book > Medical Science |
Depositing User: | Unnamed user with email support@southsbook.com |
Date Deposited: | 11 Apr 2023 07:24 |
Last Modified: | 24 May 2024 06:59 |
URI: | http://research.europeanlibrarypress.com/id/eprint/441 |